The Joint Commission

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 9 Next »

Return to the Table of Contents

Topics Covered in this section:

  • Opioid measure reporting

 7.1: Is the safe use of opioid measure voluntary?

For CY2023: for Joint Commission reporting purposes applicable to CY2023, the “Safe Use of Opioids - Concurrent Prescribing” measure is a voluntary eCQM, and may be submitted as one of the self-selected measures.

For CY2024: for Joint Commission reporting purposes applicable to CY2024, the “Safe Use of Opioids - Concurrent Prescribing” measure is a required measure for Large Acute Care Hospitals. It remains optional for Small and Critical Access Hospitals.

 7.2: How many quarters is the Safe Use of Opioids eCQM reported?

The Safe Use of Opioids measure is submitted the same as any other eCQM, based on the calendar year requirements.

 7.3: What criteria does the Opioid eCQM look for?

CMS eCQM specifications can be found on the CMS eCQI Resource Center website. The direct link to the Safe Use of Opioids - Concurrent Use measure is: https://ecqi.healthit.gov/ecqm/eh/2021/cms506v3

 7.4: Where can we find the specifications for the eCQM Safe Use of Opioids - Concurrent Prescribing?

CMS eCQM specifications can be found on the CMS eCQI Resource Center website. The direct link to the Safe Use of Opioids - Concurrent Use measure is below
https://ecqi.healthit.gov/ecqm/eh/2021/cms506v3

Continue to the next section: Direct Data Submission Platform - General Information

Return to the Table of Contents

  • No labels

©The Joint Commission, All Rights Reserved
The Joint Commission is a registered trademark of The Joint Commission.